Your Article Summary
Decision About European Marketing Authorization for Oracea Postponed to 2008
MediGene, 07/31/07
MediGene AG has been informed by CollaGenex Pharmaceuticals Inc., that the decision about the European marketing authorization for the drug Oracea has been postponed. The committee of the nine countries involved in the decentralised procedure (Coordination Group for Mutual Recognition and Decentralised Procedures, CMD) did not reach a unanimous decision, and therefore refers the procedure to another committee for decision-making
| Previous Article | Next Article |
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Wyeth Winds Up With New Pristiq Campaign
PharmExec, 06/11/09
MediciNova and Avigen Confirm Understanding for Key Terms for a Business Combination
Avigen, 06/26/09
Emerging markets & emerging needs: Developing countries vaccine manufacturers' perspective & its current status
Biologicals, 06/08/09
Article Search
Sponsor


See Latest Articles


